Sunitha Yanamadala
University of Michigan
22 Papers
350 Citations
Sunitha Yanamadala is an academic researcher from University of Michigan. The author has contributed to research in topics: Myocardial infarction & Coronary artery disease. The author has an hindex of 16, co-authored 22 publications. Previous affiliations of Sunitha Yanamadala include SUNY Downstate Medical Center.
Chat about Author
Papers
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction.
Erdal Cavusoglu,Erdal Cavusoglu,Cyril Ruwende,Vineet Chopra,Sunitha Yanamadala,Calvin Eng,Luther T. Clark,David J. Pinsky,Jonathan D. Marmur +8 more
TL;DR: In a cohort of male patients undergoing coronary angiography, a single baseline determination of plasma TIMP-1 is independently predictive of the subsequent risk of death and MI.
137
Usefulness of Baseline Plasma Myeloperoxidase Levels as an Independent Predictor of Myocardial Infarction at Two Years in Patients Presenting With Acute Coronary Syndrome
Erdal Cavusoglu,Erdal Cavusoglu,Cyril Ruwende,Calvin Eng,Vineet Chopra,Sunitha Yanamadala,Luther T. Clark,David J. Pinsky,Jonathan D. Marmur +8 more
TL;DR: Investigation of the long-term prognostic significance of baseline MPO levels in a well-characterized cohort of 193 men with ACS demonstrates that baselineMPO levels independently predict MI at 2 years in patients with ACS.
135
Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography.
Erdal Cavusoglu,Erdal Cavusoglu,Cyril Ruwende,Vineet Chopra,Shyam Poludasu,Sunitha Yanamadala,William H. Frishman,Calvin Eng,David J. Pinsky,Jonathan D. Marmur +9 more
TL;DR: Investigating the long-term prognostic significance of baseline plasma ADMA levels in a well-characterized cohort of 170 high-risk diabetic men with known or suspected coronary artery disease demonstrated that elevated baseline levels of ADMA are a strong and independent predictor of cardiovascular outcomes (including all-cause mortality) in patients with DM.
64
Riboflavin-mediated reduction of oxidant injury, rejection, and vasculopathy after cardiac allotransplantation.
Koichiro Iwanaga,Tomomi Hasegawa,Donald E. Hultquist,Hiroaki Harada,Yasushi Yoshikawa,Sunitha Yanamadala,Hui Liao,Scott H. Visovatti,David J. Pinsky +8 more
TL;DR: Riboflavin administered in the setting of cardiac allograft transplantation appears to be a powerful means to reduce early graft lipid peroxidation, leukocytic infiltration, and cytokine production as well as to suppress the late development of cardiacAllograft vasculopathy.
64
Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis.
Erdal Cavusoglu,Erdal Cavusoglu,Elizabeth Kornecki,Malgorzata B. Sobocka,Anna Babinska,Yigal H. Ehrlich,Vineet Chopra,Sunitha Yanamadala,Cyril Ruwende,Moro O. Salifu,Luther T. Clark,Calvin Eng,David J. Pinsky,Jonathan D. Marmur +13 more
TL;DR: Plasma F11R is independently associated with the presence and severity of angiographically defined CAD and may be an important mediator of the effects of inflammation on the vessel wall by virtue of its strong correlation to plasma TNF-alpha.
61